Research platform using transient expression of morphogenic transcription factors to reprogram cell fate and improve regeneration efficiency in tissue culture, with applications in gene editing for recalcitrant crop species such as wheat.
This research program addresses a persistent bottleneck in plant biotechnology: the difficulty of regenerating whole plants from cultured cells, particularly in crop species that are recalcitrant to standard tissue culture methods. The approach centers on the transient expression of specific morphogenic transcription factors that can reprogram cell identity toward embryonic or shoot-meristem states, unlocking totipotency in systems where conventional growth regulator treatments alone are insufficient. By systematically screening and combining these factors, the program aims to dramatically improve regeneration efficiency in both model and crop systems, enabling faster and more reliable production of edited plants.
Core approach:
Key findings to date:
Potential applications:
The technology is currently at an early-to-mid stage of development. A functional protoplast regeneration pipeline has been established in Arabidopsis, and initial validation of morphogenic factors (including WIND1) has demonstrated measurable improvements in regeneration efficiency. Ongoing work aims to extend these findings to wheat through both stable and transient transformation approaches, with a proof-of-principle gene editing and regeneration experiment planned through protoplast culture. The program is positioned to advance from laboratory validation toward broader crop species application, with active collaboration with a small grains breeding program to support translational relevance.
Virginia Polytechnic Institute and State University (Virginia Tech) is a comprehensive public land‑grant research university with broad graduate and professional programs and a strong industry orientation. An adjacent research and technology park links companies with faculty, shared labs, and prototyping resources, while facilities in the National Capital Region create a direct connection to federal partners and supply‑chain collaborators. Integration with a regional health system supports clinical research and translational pathways, and the statewide extension network enables field deployment and validation with industry and communities. Research is supported by competitive federal funding from agencies such as NSF, NIH, DOE, USDA, and the Department of Defense. A dedicated technology transfer office provides IP management, licensing, startup formation, and industry contracting support.